Determination of terbutaline sulfate and its degradation products in pharmaceutical formulations using LC

Journal of Pharmaceutical and Biomedical Analysis

Volumn 29, Issue 5, 2002, Pages 927-937

  Daraghmeh, N ^a   Al Omari, M M ^a   Sara, Z ^a   Badwan, A A ^a   Jaber, A M Y ^b  

^a JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

^b KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS   (Saudi Arabia)

Author keywords

Chromatographic purity; HPLC; Stability indicating assay; Terbutaline sulfate

Indexed keywords

1 (3,5 DIHYDROXYPHENYL) 2 [(1,1 DIMETHYLETHYL)AMINO]ETHANONE; 3,5 DIHYDROXYBENZALDEHYDE; ACETIC ACID; ALPHA RESORCYLIC ACID; AMMONIUM SULFATE; BENZALDEHYDE DERIVATIVE; METHYL GROUP; TERBUTALINE SULFATE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CALIBRATION; DRUG DEGRADATION; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG FORMULATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; TABLET;

BRONCHODILATOR AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; PHARMACEUTICAL PREPARATIONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TERBUTALINE;

EID: 0037205819     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00216-9     Document Type: Article

References (17)